- Report
- May 2022
- 116 Pages
Global
From €3999EUR$4,500USD£3,463GBP
- Report
- July 2024
- 150 Pages
Global
From €3333EUR$3,750USD£2,886GBP
- Report
- June 2024
- 90 Pages
United States
From €3111EUR$3,500USD£2,693GBP
- Report
- February 2024
- 112 Pages
Global
From €4222EUR$4,750USD£3,655GBP
- Report
- February 2024
- 114 Pages
Global
From €4222EUR$4,750USD£3,655GBP
- Report
- February 2024
- 114 Pages
Global
From €4222EUR$4,750USD£3,655GBP
- Report
- April 2023
- 68 Pages
Japan
From €4222EUR$4,750USD£3,655GBP
- Report
- April 2023
- 71 Pages
North America
From €4222EUR$4,750USD£3,655GBP
- Report
- April 2023
- 89 Pages
Saudi Arabia
From €4222EUR$4,750USD£3,655GBP
- Report
- April 2023
- 81 Pages
Spain
From €4222EUR$4,750USD£3,655GBP
- Report
- April 2023
- 70 Pages
Canada
From €4222EUR$4,750USD£3,655GBP
- Report
- January 2022
- 68 Pages
South Africa
From €4222EUR$4,750USD£3,655GBP
- Drug Pipelines
- July 2022
- 60 Pages
Global
From €2000EUR$2,250USD£1,731GBP
- Report
- July 2024
- 115 Pages
Global
From €4222EUR$4,750USD£3,655GBP
- Report
- February 2024
- 116 Pages
Global
From €4222EUR$4,750USD£3,655GBP
- Report
- February 2024
- 90 Pages
Argentina
From €4222EUR$4,750USD£3,655GBP
- Report
- February 2024
- 115 Pages
Global
From €4222EUR$4,750USD£3,655GBP
- Report
- February 2024
- 115 Pages
Global
From €4222EUR$4,750USD£3,655GBP
- Report
- February 2024
- 110 Pages
Global
From €4222EUR$4,750USD£3,655GBP
- Report
- April 2023
- 100 Pages
North America
From €4222EUR$4,750USD£3,655GBP

The Deep Brain Stimulator (DBS) market is a subset of the larger Neurology Devices market. It is a rapidly growing field, with DBS devices being used to treat a variety of neurological disorders, including Parkinson's disease, essential tremor, dystonia, and obsessive-compulsive disorder. DBS works by delivering electrical stimulation to specific areas of the brain, which can help reduce symptoms and improve quality of life. The technology is also being explored for use in treating depression, addiction, and other mental health conditions.
The DBS market is highly competitive, with a number of companies offering a range of devices and services. These include Medtronic, Abbott, Boston Scientific, St. Jude Medical, and NeuroPace. Additionally, there are a number of smaller companies that specialize in DBS technology, such as NeuroSigma, NeuroPace, and NeuroSurg. Show Less Read more